Human cytomegalovirus protein RL1 degrades the antiviral factor SLFN11 via recruitment of the CRL4 E3 ubiquitin ligase complex

Author:

Nightingale Katie12ORCID,Potts Martin12ORCID,Hunter Leah M.12ORCID,Fielding Ceri A.3,Zerbe Cassie M.12,Fletcher-Etherington Alice12ORCID,Nobre Luis12ORCID,Wang Eddie C. Y.3ORCID,Strang Blair L.4ORCID,Houghton Jack W.12,Antrobus Robin12,Suarez Nicolas M.5ORCID,Nichols Jenna5ORCID,Davison Andrew J.5ORCID,Stanton Richard J.3ORCID,Weekes Michael P.12ORCID

Affiliation:

1. Cambridge Institute for Medical Research, University of Cambridge, Cambridge CB2 0XY, United Kingdom

2. Department of Medicine, University of Cambridge, Cambridge CB2 0XY, United Kingdom

3. Division of Infection and Immunity, Cardiff University School of Medicine, Cardiff CF14 4XN, United Kingdom

4. Institute for Infection and Immunity, University of London, London SW17 0RE, United Kingdom

5. Centre for Virus Research, Medical Research Council, University of Glasgow, Glasgow G61 1QH, United Kingdom

Abstract

Significance Previous proteomic analyses of host factors targeted for down-regulation by human cytomegalovirus (HCMV) have focused on early or intermediate stages of infection. Using multiplexed proteomics, we have systematically identified viral factors that target each host protein down-regulated during the latest stage of infection, after the onset of viral DNA replication. Schlafen-11 (SLFN11), an interferon-stimulated gene and restriction factor for retroviruses and certain RNA viruses, potently restricted HCMV infection. Our discovery that the late-expressed HCMV protein RL1 targets SLFN11 for proteasomal degradation provides evidence for a viral antagonist of this critical cellular protein. We therefore redefine SLFN11 as an important factor that targets DNA viruses as well as RNA viruses, offering therapeutic potential via molecules that inhibit RL1-mediated SLFN11 degradation.

Funder

Wellcome

RCUK | Medical Research Council

Publisher

Proceedings of the National Academy of Sciences

Subject

Multidisciplinary

Reference40 articles.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3